Metabolic changes of acetaminophen after intravenous administration to rats pretreated with a hepatoprotective agent, YH-439

Research Communications in Molecular Pathology and Pharmacology

Volumn 91, Issue 1, 1996, Pages 3-16

  Cho, Eunsun ^a   Jang, Seong H ^a   Lee, Jong W ^b   Kim, Nak D ^a   Lee, Myung G ^a  

^a Seoul National University   (South Korea)

^b Yuhan Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 (1,3 DITHIETAN 2 YLIDENE) 2 [N (4 METHYL 2 THIAZOLYL)CARBAMOYL]ACETIC ACID ISOPROPYL ESTER; CYSTEINE; GLUCURONIDE; GLUTATHIONE; PARACETAMOL;

ANIMAL EXPERIMENT; ARTICLE; CONJUGATION; CONTROLLED STUDY; DETOXIFICATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EXCRETION; DRUG GLUCURONIDATION; DRUG METABOLISM; INTRAVENOUS DRUG ADMINISTRATION; LIVER PROTECTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; BILE; HALF-LIFE; INJECTIONS, INTRAVENOUS; LIVER; METABOLIC CLEARANCE RATE; RATS; RATS, SPRAGUE-DAWLEY; THIAZOLES;

EID: 0030025370     PISSN: 00345164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Black, M. (1984): Acetaminophen hepatotoxicity. Ann. Rev. Med., 35, 577-593.
2. Chiou, W.L. (1979): New calculation method for the apparent drug volume of distribution and application to rational dosage regimens. J. Pharm. Sci., 68, 1067-1069.
3. Choi, E.Y., Kim, S.G., Lee, J.W., Yoo, J.K., Shin, J.K. and Kim, N.D. (submitted): Suppression of rat hepatic CTP2E, by YH-439, an experimental hepatoprotectant: Protective role against hepatic injury. Drug Metab. Dispos.
4. Coles, B., Wilson, I., Wardman, P., Hinson, J.A., Nelson, S.D. and Ketterer, B. (1988): The spontaneous and enzymatic reactions of N-acetyl-p-benzoquinoneimine with glutathione: A stopped-flow kinetic study. Arch. Biochem. Biophys., 264, 253-260.
5. Galinsky, R.E. and Levy, G. (1981): Dose- and time-dependent elimination of acetaminophen in rats: Pharmacokinetic implications of cosubstrate depletion. J. Pharmacol. Exp. Ther., 219, 14-20.
6. Galinsky, R.E., Kane, R.E. and Franklin, M.R. (1986): Effect of aging on drug-metabolizing enzymes important in acetaminophen elimination. J. Pharm. Exp. Ther., 237, 107-113.
7. Gibaldi, M. and Perrier, D. (1982): Pharmacokinetics. Second edition. Marcel-Dekker. New York.
8. Hjelle, J.J. and Klassen, C.D. (1984): Glucuronidation and biliary excretion of acetaminophen in rats. J. Pharmacol. Exp. Ther., 228, 407-413.
9. Jang, S.H., Lee, M.H. and Lee, M.G. (1994): Pharmacokinetics of acetaminophen after intravenous and oral administration to spontaneously hypertensive rats and normotensive Wistar rats. J. Pharm. Sci., 83, 810-814.
10. Jung, D. (1985): Disposition of acetaminophen in protein-calorie malnutrition. J. Pharmacol. Exp. Ther., 232, 178-182.
11. Kim, S.H., Choi, Y.M. and Lee, M.G. (1993): Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition. J. Pharmacokinet. Biopharm., 21, 1-17.
12. Koop, D.R., Crumpo, B.L., Nordbloom, G.D. and Coon, M.J. (1985): Immunochemical evidence for induction of the alcohol-oxidizing cytochrome P450 of liver microsomes by diverse agents: ethanol, imidazole, trichloroethylene, acetone, pyrazole and isoniazid. Proc. Nat. Acad. Sci., USA 82, 4065-4069.
13. Lee, W.I., Yoon, W.H., Park, J.H., Lee, J.W., Shim, C.-K. and Lee, M.G. (in press). Factors influencing the protein binding of YH-439 using an equilibrium dialysis technique. A new hepatoprotective agent. Biopharm. Drug Dispos.
14. Liu, J., Liu, Y., Madhu, C. and Klassen, D. (1993): Protective effect of oleanolic acid on acetaminophen-induced hepatotoxicity in mice. J. Pharmacol. Exp. Ther., 266, 1607-1613.
15. Mitchell, J.R., Jollow, D.J., Potter, W.Z., Gillet, J.R. and Brodie, B.B. (1973): Acetaminophen-induced hepatic necrosis, IV. Protective role of glutathione. J. Pharmacol. Exp. Ther., 187, 211-217.
16. Nelson, S.D. (1990): Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin Liver Dis., 10, 267-278.
17. Park, J.H., Lee, W.I., Yoon, W.H., Shim, C.-K., Lee, J.W. and Lee, M.G. (1994): Simultaneous determination of YH-439, a new hepatoprotective agent, and its metabolites, M1 and M2 in plasma, urine and tissue homogenates by high performance liquid chromatography. The Spring Convention of the Pharmaceutical Society of Korea. Kangwon National University, Kangwon-Do, Korea, April 22-23, Abstract p. 126.
18. rd Convention of the Pharmaceutical Society of Korea. Seoul National University, Seoul, Korea, October 21-22, Abstract p. 163.
19. Yoon, W.H., Park, J.H., Lee, W.I., Lee, J.W., Shim, C.-K. and Lee, M.G. (in press): Stability and blood partition of YH-439. A new hepatoprotective agent. J. Drug Stab.